CVS Health Corporation’s (CVS) “Hold” Rating Reiterated at Deutsche Bank AG, Report finds

CVS Health Corporation’s (CVS) “Hold” Rating Reiterated at Deutsche Bank AG, Report finds

CVS Health Corporation (NYSE:CVS)‘s stock had its “hold” rating reaffirmed by stock analysts at Deutsche Bank AG in a note issued to investors on Wednesday. They currently have a $88.00 target price on the pharmacy operator’s stock. Deutsche Bank AG’s price objective would suggest a potential upside of 14.24% from the company’s current price.

A number of other equities analysts also recently weighed in on CVS. Oppenheimer Holdings, Inc. set a $88.00 price target on shares of CVS Health Corporation and gave the stock a “buy” rating in a research note on Sunday, December 18th. Vetr downgraded shares of CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $86.51 price target on the stock. in a research note on Thursday, December 8th. Credit Suisse Group reaffirmed a “buy” rating on shares of CVS Health Corporation in a research note on Monday, December 19th. Argus reaffirmed a “buy” rating and set a $85.00 price target (down previously from $120.00) on shares of CVS Health Corporation in a research note on Thursday, November 10th. Finally, Leerink Swann reaffirmed a “buy” rating and set a $105.00 price target on shares of CVS Health Corporation in a research note on Wednesday, November 9th. Eight analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. CVS Health Corporation has an average rating of “Buy” and a consensus target price of $97.99.

Shares of CVS Health Corporation (NYSE:CVS) traded up 0.88% during trading on Wednesday, hitting $77.03. 6,788,496 shares of the company were exchanged. CVS Health Corporation has a 12 month low of $69.30 and a 12 month high of $106.67. The stock has a market cap of $82.15 billion, a P/E ratio of 16.51 and a beta of 0.85. The company’s 50-day moving average price is $79.89 and its 200 day moving average price is $85.31.

The firm also recently declared a quarterly dividend, which was paid on Thursday, February 2nd. Stockholders of record on Tuesday, January 24th were issued a $0.50 dividend. The ex-dividend date was Friday, January 20th. This is a positive change from CVS Health Corporation’s previous quarterly dividend of $0.43. This represents a $2.00 annualized dividend and a dividend yield of 2.60%. CVS Health Corporation’s payout ratio is 42.83%.

Several hedge funds and other institutional investors have recently bought and sold shares of CVS. Barrow Hanley Mewhinney & Strauss LLC increased its stake in shares of CVS Health Corporation by 100.9% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 18,280,528 shares of the pharmacy operator’s stock valued at $1,442,516,000 after buying an additional 9,180,492 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of CVS Health Corporation by 48.4% in the third quarter. Price T Rowe Associates Inc. MD now owns 14,400,092 shares of the pharmacy operator’s stock valued at $1,281,464,000 after buying an additional 4,699,619 shares in the last quarter. Parnassus Investments CA increased its stake in shares of CVS Health Corporation by 43.4% in the third quarter. Parnassus Investments CA now owns 5,805,530 shares of the pharmacy operator’s stock valued at $516,634,000 after buying an additional 1,758,049 shares in the last quarter. Boston Partners increased its stake in shares of CVS Health Corporation by 48.3% in the third quarter. Boston Partners now owns 4,474,349 shares of the pharmacy operator’s stock valued at $398,172,000 after buying an additional 1,456,835 shares in the last quarter. Finally, Canada Pension Plan Investment Board increased its stake in shares of CVS Health Corporation by 101.7% in the third quarter. Canada Pension Plan Investment Board now owns 2,807,795 shares of the pharmacy operator’s stock valued at $249,866,000 after buying an additional 1,415,802 shares in the last quarter. 81.39% of the stock is owned by institutional investors and hedge funds.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

Related posts

Leave a Comment

CVS Health Corporation’s (CVS) “Hold” Rating Reiterated at Deutsche Bank AG

CVS Health Corporation’s (CVS) “Hold” Rating Reiterated at Deutsche Bank AG

CVS Health Corporation (NYSE:CVS)‘s stock had its “hold” rating reaffirmed by stock analysts at Deutsche Bank AG in a note issued to investors on Wednesday. They currently have a $88.00 target price on the pharmacy operator’s stock. Deutsche Bank AG’s price objective would suggest a potential upside of 14.24% from the company’s current price.

A number of other equities analysts also recently weighed in on CVS. Oppenheimer Holdings, Inc. set a $88.00 price target on shares of CVS Health Corporation and gave the stock a “buy” rating in a research note on Sunday, December 18th. Vetr downgraded shares of CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $86.51 price target on the stock. in a research note on Thursday, December 8th. Credit Suisse Group reaffirmed a “buy” rating on shares of CVS Health Corporation in a research note on Monday, December 19th. Argus reaffirmed a “buy” rating and set a $85.00 price target (down previously from $120.00) on shares of CVS Health Corporation in a research note on Thursday, November 10th. Finally, Leerink Swann reaffirmed a “buy” rating and set a $105.00 price target on shares of CVS Health Corporation in a research note on Wednesday, November 9th. Eight analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. CVS Health Corporation has an average rating of “Buy” and a consensus target price of $97.99.

Shares of CVS Health Corporation (NYSE:CVS) traded up 0.88% during trading on Wednesday, hitting $77.03. 6,788,496 shares of the company were exchanged. CVS Health Corporation has a 12 month low of $69.30 and a 12 month high of $106.67. The stock has a market cap of $82.15 billion, a P/E ratio of 16.51 and a beta of 0.85. The company’s 50-day moving average price is $79.89 and its 200 day moving average price is $85.31.

The firm also recently declared a quarterly dividend, which was paid on Thursday, February 2nd. Stockholders of record on Tuesday, January 24th were issued a $0.50 dividend. The ex-dividend date was Friday, January 20th. This is a positive change from CVS Health Corporation’s previous quarterly dividend of $0.43. This represents a $2.00 annualized dividend and a dividend yield of 2.60%. CVS Health Corporation’s payout ratio is 42.83%.

Several hedge funds and other institutional investors have recently bought and sold shares of CVS. Barrow Hanley Mewhinney & Strauss LLC increased its stake in shares of CVS Health Corporation by 100.9% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 18,280,528 shares of the pharmacy operator’s stock valued at $1,442,516,000 after buying an additional 9,180,492 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of CVS Health Corporation by 48.4% in the third quarter. Price T Rowe Associates Inc. MD now owns 14,400,092 shares of the pharmacy operator’s stock valued at $1,281,464,000 after buying an additional 4,699,619 shares in the last quarter. Parnassus Investments CA increased its stake in shares of CVS Health Corporation by 43.4% in the third quarter. Parnassus Investments CA now owns 5,805,530 shares of the pharmacy operator’s stock valued at $516,634,000 after buying an additional 1,758,049 shares in the last quarter. Boston Partners increased its stake in shares of CVS Health Corporation by 48.3% in the third quarter. Boston Partners now owns 4,474,349 shares of the pharmacy operator’s stock valued at $398,172,000 after buying an additional 1,456,835 shares in the last quarter. Finally, Canada Pension Plan Investment Board increased its stake in shares of CVS Health Corporation by 101.7% in the third quarter. Canada Pension Plan Investment Board now owns 2,807,795 shares of the pharmacy operator’s stock valued at $249,866,000 after buying an additional 1,415,802 shares in the last quarter. 81.39% of the stock is owned by institutional investors and hedge funds.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

Related posts

Leave a Comment